Meningococcal carriage: The dilemma of 4CMenB vaccine

The Lancet

Volumn 384, Issue 9960, 2014, Pages 2088-2090

  Taha, Muhamed Kheir ^a   Deghmane, Ala Eddine ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE; MENINGOCOCCUS VACCINE; NERVE CELL ADHESION MOLECULE; PLACEBO; POLYSACCHARIDE VACCINE; STREPTOCOCCUS VACCINE;

BACTERIAL IMMUNITY; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIUM ISOLATE; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DRUG CONJUGATION; DRUG EFFICACY; HEALTH SURVEY; HERD IMMUNITY; HUMAN; IMMUNOGENICITY; INCIDENCE; NASOPHARYNX; NEISSERIA MENINGITIDIS; NOTE; PREVALENCE; SECONDARY INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION; FEMALE; HETEROZYGOTE; MALE; MENINGOCOCCAL INFECTIONS; PREVENTION AND CONTROL;

CARRIER STATE; FEMALE; HUMANS; MALE; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; NEISSERIA MENINGITIDIS, SEROGROUP B;

EID: 84917671679     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60935-1     Document Type: Note

References (13)

1. F Marc LaForce, N Ravenscroft, M Djingarey, S Viviani Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution Vaccine 27 suppl 2 2009 B13 B19
2. MC Maiden, JM Stuart Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination Lancet 359 2002 1829 1831
3. European Centre for Disease Prevention and Control Surveillance of invasive bacterial diseases in Europe 2008/2009 2011 ECDC Stockholm
4. M Eckhardt, M Muhlenhoff, A Bethe, J Koopman, M Frosch, R Gerardy-Schahn Molecular characterization of eukaryotic polysialyltransferase-1 Nature 373 1995 715 718
5. S Bambini, R Rappuoli The use of genomics in microbial vaccine development Drug Discov Today 14 2009 252 260
6. U Vogel, MK Taha, JA Vazquez et al. Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment Lancet Infect Dis 13 2013 416 425
7. J Wise Meningitis B vaccine to be introduced in UK after U turn on its cost effectiveness BMJ 348 2014 g2327
8. French High Council for Public Health The place of the Bexsero vaccine in the vaccination against invasive meningococcal infections due to serogroup B (in French) http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=386 Dec 11, 2013 (accessed Aug 14, 2014).
9. RC Read, D Baxter, DR Chadwick et al. Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial Lancet 2014 published online Aug 19. http://dx.doi.org/10.1016/S0140-6736(14)60842-4
10. J Donnelly, D Medini, G Boccadifuoco et al. Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines Proc Natl Acad Sci USA 107 2010 19490 19495
11. E Hong, MM Giuliani, AE Deghmane et al. Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa? Vaccine 31 2013 1113 1116
12. V Delbos, L Lemee, J Benichou et al. Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage Vaccine 31 2013 4416 4420
13. CL Trotter, NJ Gay, WJ Edmunds Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination Am J Epidemiol 162 2005 89 100